Main Session
Sep 28
SS 01 - CNS 1: Novel Approaches in Brain Metastases

105 - Use of Gadolinium Nanoparticles as Radiosensitizers for Brain Metastases: Results from the Phase 2 Multicentric Randomized Trial (NANORAD2)

03:20pm - 03:30pm PT
Room 152

Presenter(s)

Camille Verry, MD - Centre Hospitalier Universitaire Grenoble Alpes, Grenoble, Isere